While treatment for initial GB centers around radiotherapy and an alkylating chemotherapy drug, TMZ, multiple different agents have been studied for recurrent disease including therapeutics targeting VEGF, cell checkpoint pathways, other alkylating cancer agents, and anti-mitotic treatments; despite ample preclinical and clinical research, effective treatments do not yet exist for tumor recurrence. Here, VEGFA is linked to cancer.